ISB is partnering with Town Hall Seattle for a speaker series focusing on some of the most important topics in science and health care.
SEATTLE (PRWEB) January 02, 2020
ISB is celebrating its 20th anniversary with events throughout 2020. As part of this year-long celebration, ISB is partnering with Town Hall Seattle for a speaker series focusing on some of the most important topics in science and health care.
The first of these events will focus on brain health and will be held Thursday, March 5, 2020 in Town Hall Seattle’s Great Hall. Neuroscientist and New York Times bestselling author Dr. David Eagleman will deliver the keynote address and will take part in a panel discussion along with brain health expert Dr. Mary Kay Ross. Dr. Ross is founder and CEO of the Brain Health & Research Institute, which is a clinic that was co-founded by ISB this past September.
Other ISB-Town Hall Seattle events will focus on vaccines, STEM education and artificial intelligence in health care, and will feature notable experts in each field. More details will be available very soon.
In 2000, Drs. Lee Hood, Ruedi Aebersold and Alan Aderem created ISB as the first-ever institute dedicated to systems biology. For the past two decades, our scientists have been on the ground floor on many important research areas -- aging and wellness, computational biology, brain diseases, and many chronic and infectious diseases, to name a few. Furthermore, ISB has improved the quality of and accessibility to STEM education through curriculum development and by working with entire school systems to get students thinking like scientists.
ISB remains at the cutting edge of science. Our research is focused on using the tools of systems biology to define an individual’s state of wellness, to detect early transitions to disease, and to develop proactive interventions designed to prevent the full development of disease. We believe every patient is unique, and our affiliation with Providence St. Joseph Health, one of the nation’s largest not-for-profit health care systems, provides a pipeline to rapidly move developments from the research bench to a patient’s bedside.
Our labs are working on big problems such as developing personalized cancer treatments and harnessing an individual’s immune system to fight disease, slowing the progression of Alzheimer’s Disease and other neurodegenerative diseases, embracing machine learning to create biomedical, interpretable risk models for clinical decision support, and much more.